000			01963 a2200541 4500
005			20250514005926.0
264		0	_c20011004
008			200110s 0 0 eng d
022			_a0014-2999
024	7		_a10.1016/s0014-2999(01)01194-3 _2doi
040			_aNLM _beng _cNLM
100	1		_aCollins, S L
245	0	0	_aEffects of kappa-opioid receptor agonists on long-term cocaine use and dopamine neurotransmission. _h[electronic resource]
260			_bEuropean journal of pharmacology _cAug 2001
300			_a25-34 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnalgesics _xpharmacology
650	0	4	_aAnimals
650	0	4	_aAutoradiography
650	0	4	_aBenzazepines _xmetabolism
650	0	4	_aBenzeneacetamides
650	0	4	_aBenzomorphans _xpharmacology
650	0	4	_aBinding, Competitive _xdrug effects
650	0	4	_aBrain _xdrug effects
650	0	4	_aCarrier Proteins _xdrug effects
650	0	4	_aCocaine _xanalogs & derivatives
650	0	4	_aDopamine _xmetabolism
650	0	4	_aDopamine Plasma Membrane Transport Proteins
650	0	4	_aIodine Radioisotopes
650	0	4	_aMale
650	0	4	_aMembrane Glycoproteins
650	0	4	_aMembrane Transport Proteins
650	0	4	_aMotor Activity _xdrug effects
650	0	4	_aNerve Tissue Proteins
650	0	4	_aPyrrolidines _xpharmacology
650	0	4	_aRats
650	0	4	_aRats, Sprague-Dawley
650	0	4	_aReceptors, Dopamine _xdrug effects
650	0	4	_aReceptors, Opioid, kappa _xagonists
650	0	4	_aSulpiride _xanalogs & derivatives
650	0	4	_aSynaptic Transmission _xdrug effects
650	0	4	_aTime Factors
650	0	4	_aTyrosine 3-Monooxygenase _xdrug effects
700	1		_aD'Addario, C
700	1		_aIzenwasser, S
773	0		_tEuropean journal of pharmacology _gvol. 426 _gno. 1-2 _gp. 25-34
856	4	0	_uhttps://doi.org/10.1016/s0014-2999(01)01194-3 _zAvailable from publisher's website
999			_c11449954 _d11449954